APP and Cognitive impairment: In APP/PS1 mice, XMU-MP-1 administration protects against cognitive deficits and reverses signs of astrocytic senescence through a mechanism requiring YAP [21], demonstrating that MST1 inhibition is also beneficial in non-neuronal brain cell types.